Form 4: Astrana Health Chief Medical Officer Reports Routine Stock Disposition for Tax Obligations

Sentiment:

Insider Transaction Report


Astrana Health, Inc.'s Chief Medical Officer, Dinesh M. Kumar, reported a disposition of 1,656 shares of common stock to cover tax withholding obligations, while retaining substantial beneficial ownership.

Summary

  • Dinesh M. Kumar, Chief Medical Officer of Astrana Health, Inc. (ASTH), reported a disposition of 1,656 shares of common stock on June 4, 2025.
  • The shares were surrendered at a price of $25.06 per share to offset tax withholding obligations associated with the vesting of certain restricted stock.
  • Following this transaction, Mr. Kumar beneficially owns 225,642 shares of Astrana Health common stock.
  • The remaining beneficial ownership includes 56,754 restricted shares vesting in two equal annual installments starting January 23, 2026, and 26,927 restricted shares vesting in two equal semi-annual installments starting July 1, 2025.
  • Additionally, the holdings comprise 8,158 and 3,264 restricted shares, and 67,238 restricted stock units, all subject to the achievement of certain performance goals.
  • Another 26,701 restricted stock units will vest in eight equal semi-annual installments beginning September 5, 2025.
  • The total beneficial ownership also includes 629 shares acquired under the Issuer's Employee Stock Purchase Plan.

Sentiment

Score: 6

Explanation: The transaction is a routine tax-related disposition, which is neutral. However, the significant remaining beneficial ownership and future vesting schedules indicate continued executive alignment and long-term commitment, leaning slightly positive.

Positives

  • The Chief Medical Officer retains a substantial beneficial ownership of 225,642 shares, indicating continued alignment with shareholder interests and long-term commitment to the company.
  • A significant portion of the remaining shares are restricted stock and restricted stock units with future vesting dates, reinforcing the executive's long-term stake in the company's performance.
  • The inclusion of 629 shares acquired via the Employee Stock Purchase Plan suggests personal investment and confidence in Astrana Health.

Negatives

  • The disposition of 1,656 shares, even for tax purposes, represents a reduction in direct beneficial ownership by a key executive.

Risks

  • No specific risks beyond the general market and company-specific risks inherent in holding equity securities are mentioned in this Form 4 filing.

Future Outlook

The document outlines future vesting schedules for a significant portion of the Chief Medical Officer's equity holdings, including restricted stock vesting in annual installments starting January 23, 2026, and semi-annual installments starting July 1, 2025. Additionally, restricted stock units will vest semi-annually beginning September 5, 2025, with some grants contingent on achieving specific performance goals.

Industry Context

This Form 4 filing details a routine insider transaction for tax purposes, which is common across all industries when restricted stock or other equity awards vest. It does not provide information relevant to broader industry trends or competitive dynamics within the healthcare sector.

Stakeholder Impact

  • Minimal direct impact on shareholders as the transaction is a routine tax-related disposition and the executive retains substantial equity.
  • Employees holding similar equity awards can observe the standard process for tax withholding upon vesting.

Next Steps

  • Future vesting events for 56,754 restricted shares beginning January 23, 2026.
  • Future vesting events for 26,927 restricted shares beginning July 1, 2025.
  • Future vesting events for 26,701 restricted stock units beginning September 5, 2025.
  • Achievement of certain performance goals for 8,158 and 3,264 restricted shares, and 67,238 restricted stock units, which will trigger their vesting.

Key Dates

DateDescription
06/04/2025Date of transaction (disposition of shares by Dinesh M. Kumar).
06/06/2025Date the Form 4 was signed by the reporting person's attorney-in-fact.
07/01/2025Start of semi-annual vesting for 26,927 restricted shares.
09/05/2025Start of semi-annual vesting for 26,701 restricted stock units.
01/23/2026Start of annual vesting for 56,754 restricted shares.

Recommendation

hold

Keywords

Astrana Health, ASTH, Form 4, Insider Transaction, Stock Ownership, Chief Medical Officer, Dinesh M. Kumar, Restricted Stock, Restricted Stock Units, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.